STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) in China. The order will be delivered promptly and generate revenues in the third quarter of approximately SEK 4,8 million.
"The order we have just received from Well Lead is the first outside of the initial contract and therefore an important milestone in our cooperation, as it shows that end-customer sales in China are picking up", says Christian Kinch, CEO.
In June 2018, Bactiguard signed a combined distribution and license agreement with Well Lead, China's leading manufacturer of consumable medical devices.
The first two product orders, at a combined value of SEK 20 million, were part of the initial contract and delivered in the second and fourth quarters of 2018. The third order, which has now been received, is worth SEK 4,8 million and it is the first order outside the initial contract.
This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below 2019-09-29, at 20:00.
For further information, please contact:
Cecilia Edström
CFO and deputy CEO
mobile: +46-722-262-328
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bactiguard-holding-ab--publ-/r/new-major-order-from-china,c2920728
The following files are available for download:
190929 New major order from China |
